Platten M - Search Results

1

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.

Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C, Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw M. Singh K, et al. Among authors: platten m. Nat Med. 2023 Oct;29(10):2402-2405. doi: 10.1038/s41591-023-02464-8. Nat Med. 2023. PMID: 37488293 No abstract available.

2

Chorea as a paraneoplastic complication of Hodgkin's disease.

Batchelor TT, Platten M, Palmer-Toy DE, Hunter GJ, Lev MH, Dalmau J, Hochberg FH. Batchelor TT, et al. Among authors: platten m. J Neurooncol. 1998 Jan;36(2):185-90. doi: 10.1023/a:1005860103173. J Neurooncol. 1998. PMID: 9525818

3

Immunoadsorption therapy for paraneoplastic syndromes.

Batchelor TT, Platten M, Hochberg FH. Batchelor TT, et al. Among authors: platten m. J Neurooncol. 1998 Nov;40(2):131-6. doi: 10.1023/a:1006136219490. J Neurooncol. 1998. PMID: 9892095 Clinical Trial.

4

Role of TGF-beta in oncogenesis.

Weller M, Wick W, Platten M. Weller M, et al. Among authors: platten m. Microsc Res Tech. 2001 Feb 15;52(4):353. doi: 10.1002/1097-0029(20010215)52:4<353::AID-JEMT1019>3.0.CO;2-U. Microsc Res Tech. 2001. PMID: 11170293 No abstract available.

5

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

6

Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.

Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bähr M, Ohgaki H, Ashkenazi A, Weller M. Roth W, et al. Among authors: platten m. Cancer Res. 2001 Mar 15;61(6):2759-65. Cancer Res. 2001. PMID: 11289159

7

Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M. Wick W, et al. Among authors: platten m. J Neurosci. 2001 May 15;21(10):3360-8. doi: 10.1523/JNEUROSCI.21-10-03360.2001. J Neurosci. 2001. PMID: 11331365 Free PMC article.

8

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.

Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. Platten M, et al. Int J Cancer. 2001 Jul 1;93(1):53-61. doi: 10.1002/ijc.1289. Int J Cancer. 2001. PMID: 11391621 Free article.

9

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma).

Platten M, Wick W, Wischhusen J, Weller M. Platten M, et al. Br J Pharmacol. 2001 Nov;134(6):1279-84. doi: 10.1038/sj.bjp.0704373. Br J Pharmacol. 2001. PMID: 11704648 Free PMC article.

10

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Wick W, Platten M, Weller M. Wick W, et al. Among authors: platten m. J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page